Evidence map›Paper›PMID 40260638›Full record

ArticleJournal of cell science2025

EdU tracking of leukocyte recruitment in mouse models of ischemic stroke and sterile lung inflammation.

Erika Arias, Maureen E Haynes, Neil A Nadkarni, Zoie K Lipfert, William A Muller, Ayush Batra, David P Sullivan

Abstract read
In one paragraph

Article in Journal of cell science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Toward development of a dynamic supramolecular peptide therapy for acute ischemic stroke.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Article
  5. Article
  6. Non-Malignant Granulocyte and Monocyte Disorders: An Update.British journal of biomedical science · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Erika AriasDepartment of Pathology, Northwestern University, Chicago, IL 60643, USA.ORCID 0000-0001-9501-9553
Maureen E HaynesDepartment of Pathology, Northwestern University, Chicago, IL 60643, USA.
Neil A NadkarniDepartment of Neurology, Stony Brook University, Stony Brook, NY 11794, USA.ORCID 0000-0003-3485-1519
Zoie K LipfertDepartment of Neurology, Northwestern University, Chicago, IL 60643, USA.ORCID 0009-0000-5687-4485
William A MullerDepartment of Pathology, Northwestern University, Chicago, IL 60643, USA.ORCID 0000-0002-4802-2757
Ayush BatraDepartment of Pathology, Northwestern University, Chicago, IL 60643, USA.ORCID 0000-0002-4783-5801
David P SullivanDepartment of Pathology, Northwestern University, Chicago, IL 60643, USA.ORCID 0000-0002-7462-3898

Funding

Tumor Environment and Metastasis (TEAM) Research ProgramP30CA060553 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Devalingam Mahalingam · 1993 to 2026
$153.9M
Transendothelial Migration of Leukocytes: Developing New Paradigms in Health and DiseaseR35HL155652 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI William A Muller · 2021 to 2026
$5.1M
Defining the Spatiotemporal Underpinnings of Neutrophil Recruitment, Microvascular Flow, and Oxygenation in Ischemic StrokeK08NS121597 · NINDS · STATE UNIVERSITY NEW YORK STONY BROOK · PI Neil Avadhoot Nadkarni · 2023 to 2026
$1.1M
Aging Exacerbates Neutrophil Persistence and Negatively Impacts Stroke OutcomesR21AG086751 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI BATRA, AYUSH, SULLIVAN, DAVID PATRICK · 2024 to 2024
$440k
The Role of Neutrophils in Ischemia/Reperfusion Injury following Acute StrokeF31NS130939 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI ARIAS, ERIKA · 2023 to 2025
$119k
Defining the temporospatial functions of neutrophils in acute airspace diseaseF31HL172345 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI HAYNES, MAUREEN · 2024 to 2024
$44k
NCI NIH HHS P30 CA060553NHLBI NIH HHS F31 HL172345NHLBI NIH HHS R35 HL155652NIA NIH HHS R21 AG086751NIH HHS NS130939NINDS NIH HHS F31 NS130939NINDS NIH HHS K08 NS121597Northwestern University
6 · The paper itself

Abstract

The discovery of copper(I)-catalyzed azide-alkyne cycloaddition (click chemistry) has significantly advanced the detection of proliferating cells by utilizing 5-ethynyl-2'-deoxyuridine (EdU). EdU, a thymidine analogue, is incorporated into DNA during replication and detected by the direct reaction with an azide-conjugated fluorophore. Traditionally, dividing cells are labeled using 5-bromodeoxyuridine (BrdU), another nucleotide analogue. However, BrdU detection is a harsh method that requires substantial sample processing, unlike EdU detection. EdU is classically used to identify proliferating cells; however, we report a streamlined methodology that uses EdU to label and track leukocyte recruitment that is compatible with flow cytometry and microscopy and preserves transgenic fluorophores. EdU labeling was performed in two different models of sterile inflammation: ischemic stroke and hydrochloric acid aspiration. EdU injection was timed to differentially label circulating monocytes, neutrophils and T cells. Tissue analysis showed EdU-positive monocytes and T cells were enriched in both inflammatory models. This suggests that recently divided monocytes and T cells are preferentially recruited to these vascular beds during inflammation and highlights the utility of this labeling approach to track leukocyte subtypes longitudinally during inflammation.

Indexed as

Cell TrackingDeoxyuridineIschemic StrokeLeukocytesPneumoniaAnimalsClick ChemistryDisease Models, AnimalMiceMice, Inbred C57BLMonocytesNeutrophils5-ethynyl-2'-deoxyuridineDeoxyuridineEdUInflammationLeukocyte recruitmentStroke

Identifiers

PMID40260638
PMCPMC12136169

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.